Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05453903
Title A Study of JNJ-75276617 in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC

acute myeloid leukemia


JNJ-75276617 + Venetoclax

Azacitidine + JNJ-75276617 + Venetoclax

Azacitidine + JNJ-75276617

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU

Additional content available in CKB BOOST